Further, survival analysis indicated that CRC patients with ≥10 FcRn+CD11c+ cells per observed area had significantly longer survival times over a 70-month follow up than did those with <10 FcRn+CD11c+ cells in the tumor microenvironment (37). Here, ITGAX is linked to colorectal carcinoma.